CCG203971 是一种Rho/MRTF/SRF通路抑制剂，具有潜在的抗转移作用。它有效靶向 RhoA/C 激活的 SRE 荧光素酶，IC50为 6.4 μM。它抑制 PC-3 细胞迁移，IC50为 4.2 μM。
产品描述
CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM. This compound also inhibits PC-3 cell migration (IC50: 4.2 μM), as determined by a scratch wound assay. CCG-203971 causes no cytotoxicity when evaluated by the WST-1 assay. It is well tolerated in normal mice up to doses of 100 mg/kg given intraperitoneally over five days.
Cas No.
1443437-74-8
分子式
C23H21ClN2O3
分子量
408.88
别名
CCG203971
储存和溶解度
DMSO:73 mg/mL(178.5 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
